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ABSTRACT 
 
Bronchopulmonary Dysplasia, Idiopathic Pulmonary Arterial Hypertension, and Wave 
Modeling in Stented Vessels. (April 2009) 
 
Andrew Milton Peters 
Department of Biomedical Engineering 
Texas A&M University 
 
Research Advisor: Dr. James E. Moore 
Department of Biomedical Engineering 
 
Despite the many advances in medicine, bronchopulmonary dysplasia (BPD) remains a 
major obstacle for survival in neonates. Recent studies have fostered interests in the 
effects of hemodynamics on the disease’s progression and in potential treatment 
strategies to optimize those effects on pulmonary vascular development. We proposed 
the application of a stent to alter wave phenomena in the pulmonary vasculature and 
utilized a monocroatiline porcine model of another pulmonary vascular disease, 
pulmonary arterial hypertension (PAH), to identify the hemodynamic attributes which 
could be altered to ameliorate the progression of these diseases. We then simulated 
blood flow through five, simple finite element vessel models to determine the effects of 
stents on wave propagation. Our porcine model showed a significant increase in the 
impedance moduli (|Z|), a 200% increase in the characteristic impedance (ZC), and a 30% 
decrease in pulmonary vascular resistance (PVR) in the diseased subjects (n=4) 
compared to the controls (n=3). In our simulations, we noticed a large decrease in the |Z| 
and a 50-70% decrease in ZC with the deployment of a stent. We also noticed an 
  iv 
increased difference in |Z| and ZC between the upstream and downstream ends of the 
vessel indicating that stiffened regions of a vessel created by a stent do alter wave 
propagation within the vessel. In our porcine models, we concluded that the changes in 
the ZC could reflect the remodeling of the pulmonary vasculature in response to the 
disease’s progression, and, since the PVR was lower than the controls in these subjects, 
we hypothesized that the remodeling of the vasculature has not progressed enough to see 
the increase in mean pressure and PVR yet. This observation could have indicated that 
the disease was in an earlier stage that is synonymous with the early, undetected stages 
of PAH in humans. We also concluded that the small observed changes in the pressure 
and flow in our simulations, small size of the stent, and the current stent complications 
would prevent them from provoking an adequate global response to mediate the disease 
state and its progression.  
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NOMENCLATURE 
 
BPD Brochopulmonary Dysplasia 
DH Diaphragmatic Hernia 
IPAH Idiopathic Pulmonary Arterial Hypertension 
NHICHHD National Inst. of Child Health and Human Development 
NHLBI National Heart, Lung and Blood Institute 
ORD  Office of Rare Diseases 
FPAH Familial Pulmonary Arterial Hypertension 
PAH Pulmonary Arterial Hypertension 
PVR Total Pulmonary Vascular Resistance 
ZC Characteristic Impedance 
P Pressure 
Q Flow 
Z Impedance 
P  Mean Pressure 
Q  Mean Flow 
t Time 
|P| Pressure Modulus 
|Q| Flow Modulus 
|Z| Impedance Modulus 
 
  viii 
θQ Flow Phase 
θP Pressure Phase 
Pm Measured Pressure  
Pf Forward Propagating Pressure Waves 
Pb Retrograde Propagating Pressure Waves 
Qm Measured Flow 
Qf Forward Propagating Flow Waves 
Qb Retrograde Propagating Flow Waves 
ED Energy Delivered 
PD Power Delivered 
FEM Finite Element Modeling 
c Wave Speed 
A Area 
C Compliance  
V Velocity of Blood 
CMS Compliance Matching Stent 
CMSP CMS-Rigid Stent Hybrid Oriented Proximally 
CMSD CMS-Rigid Stent Hybrid Oriented Distally 
CS1 Control Subject One 
CS2 Control Subject Two 
CS3 Control Subject Three 
DS1 Diseased Subject One 
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DS2  Diseased Subject Two 
DS3 Diseased Subject Three 
DS4 Diseased Subject Four 
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CHAPTER I 
INTRODUCTION 
 
Despite the many recent and effective advances in the care and treatment given to 
preterm infants, bronchpulmonary dysplasia (BPD) and diaphragmatic hernias (DH) still 
foster major obstacles to infant survival.  Both conditions cause major problems 
associated with the development and health of neonate lungs and their associated 
vasculature which inevitably become exacerbated following exposure to extrauterine 
life.  These different disease conditions and their pathologies encourage research in 
alternative treatments for both conditions.  Lately, research has broadened, advocating a 
focus on the development of the vasculature of fetal lungs, and the effects of the 
pulsatile nature of blood flow on pulmonary vasculature morphogenesis. 
 
Recent work and studies performed by Rolland et al [1] have focused on the issue of 
pulsatile hemodynamics in vascular dysfunction caused by BPD and DH.  The objective 
of the study intended primarily to investigate the effectiveness of an endothelin receptor 
antagonist on pulmonary perfusion and the survival of BPD/DH, preterm Merinos 
d’Aries lambs.  The study’s results concluded with possible therapeutic treatment 
approaches for DH and BPD that focused on the pulsatile forward and backward nature 
of blood flow in the fetal vasculature.  This study included the concept of a filtering 
device designed to discourage backward flow and limit the afterload, or the return of 
mechanical energy, to the developing heart.  Such a therapeutic device would then serve 
_______________ 
This thesis follows the style of Journal of Biomechanical Engineering. 
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to encourage pulmonary development and post-natal survival [1] by reducing the 
workload of the heart or altering any possible physiological stimuli in the larger arteries 
near the heart. 
 
If such a therapeutic device does affect the physiological environment in the upstream 
vessels, it could possibly be applied to other vascular diseases in which pathological 
signals could be altered in the larger vessels to either relieve strain or possibly slow or 
halt the progression of the disease and remodeling of vascular tissues.  One such disease 
includes idiopathic pulmonary arterial hypertension (IPAH) which is a disease that 
affects the adult pulmonary vasculature. The causes and pathological signals which 
govern the progression of this fatal disease remain uncertain, but vascular remodeling 
plays a role in its development. 
 
With the heterogeneity associated in vessels with implanted stents, the application of a 
stent poses as a possible backward wave filtering device.  Our investigation into the 
effects of a stent’s elastic properties on wave phenomena could determine whether it is 
rational to investigate the use of stents to alter the physiological environment in diseased 
vasculature. 
 
Bronchopulmonary dysplasia and diaphragmatic hernias 
The technology and care of preterm infants has come a long way since Northway and his 
colleagues first proposed a definition of BPD in 1967 [2,3] as a lung injury that 
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developed as a consequence of mechanical and oxygen ventilation.  The original 
pathology of the disease included fibrosis, inflammation, and a lack of development in 
infant lungs.  Current treatment practices, including the application of surfactant and 
more gentle ventilation techniques, have increased the chances of survival and altered 
the pathology and diagnosis of BPD.  There have been recent efforts by groups, 
including the National Institute of Child Health and Human Development (NHICHHD), 
National Heart, Lung and Blood Institute (NHLBI), and the Office of Rare Diseases 
(ORD), to redefine BPD to allow physicians to better identify and diagnose it.  
Currently, infants suffering from BPD have become gradually younger and more fragile 
as the newer, improved standards and treatments have developed requiring a more 
current, mature definition to reflect the pathology and diagnosis of infants with BPD [2].  
Recent investigations suggest that infants currently suffer less from fibrosis, and more 
from inflammation and abnormalities in the alveoli and the microvasculature [3], so the 
“new” [2] definition describing the diagnosis of BPD in infants has become focused 
more closely on lung tissues with impaired development caused by trauma which create 
adverse morphogenic responses in the premature lung tissues [2,3]. 
 
Usually BPD seen in infants is attributed to the developing tissues response to oxygen 
and ventilation techniques, but in the study done by Rolland and colleagues, the BPD 
found in the fetal lambs ensued from diaphragm hernias created by prenatal surgery.  
Their post procedure investigation of the lung tissue indicated abnormal lung 
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development consistent with the pathologic hypoplastic lungs, seen in many cases of 
DH, and inadequate vasculature development [4]. 
 
Idiopathic pulmonary arterial hypertension (IPAH) 
Pulmonary hypertension is a vascular disease defined by an increase in the vascular 
pressure (>25 mmHg at rest or >30 mmHg during increased activity) [5,6] of the 
normally low pressure, high flow vasculature of the lungs.  An increase in vascular 
resistance of the pulmonary tree caused by constriction of the downstream vessels leads 
to the development of the elevated blood pressure.  The constriction is related to the 
vascular remodeling of the vessels in response to various stimuli.  This increase in 
resistance places a larger after load on the heart as it moves blood through the pulmonary 
vasculature eventually leading to right ventricular dysfunction and failure [7]. 
 
In many cases pulmonary hypertension is a secondary disease caused by another 
underlying pathological condition, however IPAH is not linked to other diseases or 
conditions, and its cause is uncertain.  Research has recently associated this condition to 
chemical, environmental, and genetic factors, and, as a result, the disease has been 
further classified into familial pulmonary arterial hypertension (FPAH - more 
predominantly linked to genetic factors and family history) and IPAH [7,8].  The 
incidence of IPAH is not currently known, but there are approximately 300 new cases a 
year in the United States with a tendency toward women between the ages of 21 and 40 
and a median survival of 2.8 years [7,9].   Diagnosis of IPAH proves difficult in the 
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clinical setting because many of its symptoms closely correlate to other cardiovascular 
and pulmonary diseases, and all other possibilities must be ruled out prior to its 
diagnosis.  Current treatments for IPAH alleviate the symptoms and slow the progression 
of the disease however no cure exists, and the average length of survival for a patient 
diagnosed with IPAH is only three years [10]. 
 
Current research into IPAH revolves around genetic factors, vasoactive compounds, 
cellular signaling, and the cellular pathways that lead to the development of pulmonary 
vascular remodeling.  Since a low clinical occurrence of IPAH exists, a number of 
experimental models have been developed to study the different factors that attribute to 
FPAH and IPAH which include hypoxic and chemically induced pulmonary 
hypertensive animal models [8,11]. 
 
Wave propagation in human vasculature 
An abundance of wave phenomena can be observed in a variety of periodic events which 
occur in nature and our modern world.  The idea of a wave can be easily conveyed to 
most people with a guitar string or waves in a puddle, but waves can also be found in 
more complex systems such as those found in biology.  Blood flow and the human 
vascular tree is a prime example of wave propagation in a complex, physiological 
system as the energy generated by the heart pulses through the vascular tree propelling 
blood through the various tissues of the body.   This pulse of energy can be felt at 
various points in the body at different times, and, as an example, can be best experienced 
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with simultaneous arterial pulse measurements taken at the carotid and radial artery 
where the slight time difference in the arrival of the pulse can be felt by any observer. 
 
Now, to better visualize this propagating pulse of mechanical energy, one can imagine a 
blood vessel as a long tube filled with fluid and extend this image to two different, 
simplified cases.  In the first case, we could assume that the fluid in the tube is 
compressible while tube is long and rigid.  If we apply a force to a piston which encloses 
the fluid at one end of the tube or similarly add a small amount of liquid at the enclosed 
end, a compressed segment of the fluid would propagate down the tube in a longitudinal 
fashion similar to sound traveling through air or a compression in a slinky. Alternatively, 
we can consider fluid in the tube as incompressible and assume we have an elastic tube 
which dilates in response to an increase in pressure.  In this case, when we apply the 
same force with the piston or add the same amount of fluid, a segment of the tube would 
dilate in response to the increase in pressure. The dilated vessel segment would then 
travel down the tube in a transverse manner similar to a wave traveling on a string 
propelling blood with it.   
 
These ideas of wave travel in simple fluid models can be extended to blood flow in the 
viscoelastic blood vessel with the heart supplying the force of the piston or excess fluid.  
However, when we expand this idea of a traveling wave from a vessel to a vascular tree, 
we must begin to consider wave reflections and changes in the media through which a 
wave is traveling.  As with other waves, any change in the medium will return a certain 
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amount of energy as a reflection which can create a significant amplification.  If this 
amplification is difficult to understand, consider for an example, sound waves produced 
by a dog barking in an enclosed room.  Assuming the walls are not too thick, anyone 
passing by the room could hear the muffled dog bark as the sound waves traverse 
through the walls of the room to the individual, but, for anyone in the room, the barking 
would be louder than normal because the dog’s bark would echo off the walls.  In this 
situation, only a portion of the energy of the dog’s bark passes from the air into the much 
denser wall while the rest reflects back away from the wall into the room.  An individual 
inside the room then hears the accumulation of the reflected sound waves and the initial 
bark amplifying the noise.   
 
Thus, in the same way that the change from air to solid wall reflects a portion of a sound 
wave, any changes in a vessel, such as changes in radius, stiffness, or geometric path 
(e.g. bifurcations), would also cause a reflection, and, with the numerous bifurcations 
and vessel changes in a human vascular tree, there are a number of wave reflections 
which accumulate with every beat of the heart.  In the body, this accumulation of wave 
reflections contribute to the oscillatory, AC, component of blood flow and can form a 
significant return of energy to the heart which creates a resistive force against which the 
heart must drive blood. 
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The wave equation and wave speed 
The wave equation for blood flow though a vessel can be derived from a Eularian 
perspective of flow through a segment of an artery.  Assuming that the vessel is a 
straight compliant tube with an inviscid fluid and assuming the wave speed is much 
larger than blood velocity, we can begin with Euler’s equation for flow: 
x
p
x
uu
t
u
∂
∂−=∂
∂+∂
∂
ρ
1    (1) 
where u is the blood velocity, t is time, x is the length down the vessel, ρ is the density of 
the fluid, and p is pressure.  By nondimmensionalizing u, we can reduce Euler’s equation 
to 
x
p
t
u
∂
∂−=∂
∂
ρ
1     (2) 
Then applying the conservation of mass, we find 
0)( =∂
∂
x
Au     (3) 
where A is the cross sectional area of the vessel.  We can then derive the wave equation 
assuming small deformations by finding 
2
2
2
2 2
t
r
r
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x
r
∂
∂=∂
∂ ρ    (4) 
where r is the radius and k is a constant that describes the small deformation in radius in 
response to changes in pressure ( )pr ∂∂ / .  Expanding on this idea, we next apply the law 
of Laplace and assume that the vessel wall is linearly elastic to derive Moens-Kortweg 
equation for wave speed, c: 
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ρr
Ehc
2
=     (5) 
where E is the elasticity of the vessel and h is the thickness of the vessel wall [12,13].  
 
When solving the wave equation with any given c, we would be looking for a solution, 
U, similar to d’Alembert’s solution for a traveling wave: 
)()(),( txBtxAtxU ⋅−+⋅+= αα   (6) 
which can be found by applying the proper initial and boundary conditions to the given 
wave problem [14,15]. 
 
Stents 
In America’s modern healthcare, cardiovascular disease remains a major health concern 
afflicting an estimated 80.7 million people in the United States with high blood pressure, 
coronary artery disease, stroke, or heart failure.  Atherosclerosis, a progressive disease in 
which the build of plaque leads to an occlusion of the vessel, has proven to be a major 
contributor in the development and progression of cardiovascular disease [16], and a 
variety of endovascular treatment options exist for patients including arterial bypass, 
stenting, balloon angioplasty, and endovascular aneurysm repair [17]. 
 
In simple terms, a stent can be considered a rigid cage designed to prop open an 
occluded blood vessel to restore blood flow through an artery and provide support as the 
vessel heals following balloon angioplasty.  During balloon angioplasty, a cardiologist 
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threads a catheter with a balloon tip through the arterial tree to the site of the occlusion 
where the balloon is inflated to push open the plaque and vessel wall to reestablish blood 
flow.  This procedure places increased mechanical stress on the vessel potentially 
damaging the vessel and leading to a variety of complications including reocclusion.   
The placement of a stent in the reopened vessels seeks to decrease the occurrence of this 
problem by providing a scaffold to support the vessel as it heals following the procedure.  
 
Stenting comes with its own disadvantages and complications.  The placement of a 
foreign, metallic stent in an artery elicits a normal immunological response in the body 
which includes inflammation, thrombosis, and smooth muscle cell proliferation, and this 
response can lead a variety of complications including restenosis [18,19] of the vessel 
which would require an additional procedure to reopen or restent the vessel.  Thus, a lot 
of investment has been placed into stent design and implementation.   
 
Advances in stent design include the development of drug eluting stents which release 
chemicals designed to locally suppress the body’s immune response, yet research also 
goes into the mechanical properties of stent designs with the intent to develop new stents 
which optimize the beneficial mechanical properties of the stent while minimizing the 
mismatch between the stent and the surrounding vessel hopefully decreasing the 
magnitude of the immunological response and reduce the chance of reocclusion and 
failure [18,19]. 
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The filter concept 
The placement of a stent within a vessel doesn’t just evoke an immune response; it also 
alters the mechanical properties of a vessel.  The presence of the rigid cage of a stent 
within a vessel creates a vessel segment which contrasts the viscoelastic arterial tissue 
around it while also changing the stresses and strains placed on the vascular tissue.  This 
heterogeneity alters the local characteristics of the vessel thereby modifying the medium 
through which a pulse wave travels in the vessel.  It is this property in which our 
investigation is focused as we question whether or not this stiffened region of vascular 
tissue serves to resist or alter the return of backward flow within the human vasculature 
or whether it conceals any higher frequency signal content, measured in pressure and 
flow, which could possibly alter physiological stimuli or signals.  
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CHAPTER II 
METHODS 
Since the intent of this investigation was to determine whether or not the application of a 
stent serves to alter any physiological signals or reduce the return of the backward 
propagating waves within the human vasculature, we needed to identify the presence or 
characteristics of backward propagating waves or pathological signals within the human 
vasculature by hemodynamically investigating the pathological conditions of a 
pulmonary vascular disease.  We also needed to establish a simple analytical model to 
predict the effect of a stent on wave propagation in the simplest situation.  This model 
could then serve as a foundation for future evaluation should our results warrant further 
investigation.  The hemodynamic analysis of the vascular disease should also couple the 
two parts of our investigation by providing a methodical approach to analyze the stent 
models and quantify any induced changes in the presence of a stent. 
 
PAH analysis 
Though the idea of the application of a wave filtering device evolved from the 
evaluation of the pathological hemodynamics associated with BPD/ DH vasculature, the 
accessibility and analysis of the PAH test data proved to be more beneficial to this study.  
The PAH data and evaluation was provided by Rolland and colleagues, and it consisted 
of pressure and flow data of an adult porcine, PAH model.  In the model, PAH was 
induced by delivering monocrotaline into the pulmonary artery.  Data from four diseased 
animals and three control animals were used to analyze the impedance and reflected 
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waves of the pathological condition. The data were obtained in two multiple sets with 
the diseased measurements taken three months after PAH was induced.  Data from the 
control subjects were obtained over a period of approximately 20 seconds. The data 
obtained from four diseased animals were collected for 8 to 9 seconds. All 
measurements were taken at a rate of 500 Hz. 
 
Data from the individual cardiac cycles was isolated by two different methods. In the 
first data set, pressure and flow had been synchronized with the ECG measurements. 
Thus, we defined and separated each beat from R peak to R peak given the ECG.  Any 
abnormalities in the ECG, pressure, or flow measurements were avoided in our analysis.  
In the second data set, ECG measurements were not included so we isolated each beat 
using the foot of the pressure wave. Given measurement quality and consistent 
periodicity, we chose five to six heart beats from each of diseased subjects for analysis 
from approximately the same time intervals (e.g. the first, second, or third complete beat 
in each second).  A nearly identical approach was taken for the control data except that 
we chose more beats for a larger control group.   
 
Using Fourier analysis, pressure and flow data from each isolated beat was analyzed in 
the frequency domain using mathematical software (MATLAB R2006B, Version 7.3.0, 
The MathWorks).  We chose to leave the phase angle of each harmonic unwrapped so 
their values would not be restricted to the range between –π and π.  The characteristic 
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impedance (ZC) and pulmonary vascular resistance (PVR) was calculated through the 
application of Ohm’s law, 
Q
P
Z
ti
ti
ti
Qe
PeZe θω
θω
θω
+
+
+ =    (7) 
where P is pressure, Q is flow, Z is the impedance, ω is the frequency, and θ is the phase.  
The PVR was determined by the mean pressure ( P ) over the mean flow (Q ), the 
magnitude of the impedance (|Z|) at each frequency was determined by dividing the 
pressure magnitude by the flow magnitude, and the phase was determined by subtracting 
the flow phase ( Qθ ) from the pressure phase ( Pθ ).  The characteristic impedance (ZC) 
was computed by averaging the second through tenth harmonics. 
 
We isolated the forward and backward wave components in the time domain with the 
measured pressure (Pm), measured flow (Qm), P  , Q , and ZC following the methods 
described by Westerhof et al [13] and Quick et al [20] thereby isolating the AC 
component of the measured pressure and flow waves from the DC component using 
bfm PPPPP +=−=&   (8) 
bfm QQQQQ +=−=&   (9) 
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C
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PQ −=      (13) 
where P&  and Q&   are the oscillating or AC components of pressure and flow, and Pf, Pb, 
Qf, and Qb are the forward and backward wave components of pressure and flow, 
respectively.  
 
Since the value of ZC used in these calculations was determined from the measured 
magnitude of each harmonic, this calculation gives us a real value to use in the time 
domain.  However, it should be noted that this calculation neglects blood viscosity and 
the viscoelasticity of the pulmonary vascular tree [13]. Fig. 1 provides a summary of the 
calculations necessary for each beat in our analysis to determine the results of the 
experiment. 
 
The energy delivered (ED) to the pulmonary vasculature and the power delivered (PD) by 
the heart was also evaluated for each beat 
∫ ⋅= TD dttQtPE
0
)()(     (14) 
QPPD ⋅=      (15) 
The mean and standard deviation of P, Q, PVR, ZC, ED, and PD was calculated for each 
animal and reported as such (± SD), and we used the independent, heteroscedastic t-test 
of unequal sizes to compare the P, Q, P , Q , PVR, ZC, ED, and PD of the diseased and 
control animals to each other.  P values of 0.05 were required to be considered 
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significantly different. Averages for the controls and diseased animal sets were 
determined from the individual beats. 
 
 
Fig. 1 Sample Summary of Our Frequency and Time Domain Analysis. This figure provides a 
brief summary of the frequency and time domain results of our data analysis. Using P and Q 
measurements, the modulus and phase of the P and Q wave forms can be determined in the 
frequency domain. These are then used to calculate the Z modulus and phase. Z moduli are utilized 
to calculate the ZC which allows us to separate the measured waves into their forward and backward 
running components. 
 
Finite element vessel model 
The finite element method has been used in numerous applications to model and predict 
various physiological systems in biomechanics [21,22] including stent applications 
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within vessel models [18,19].  Finite element modeling (FEM) appeared to be the best 
method to create our simple model allowing us to focus on the properties of the stent 
within a vessel so we could identify any changes in wave propagation in the simplest 
case.  We built an FEM software program using MATLAB R2006b, Version 7.3.0 
expanding upon ideas and software methods used in previous stent investigations. The 
calculating routines and function files were developed in parallel for five different vessel 
1-D models, and the models differed only in the application of the different stent designs 
applied to each vessel.   
 
Though a variety of methods have been used to adequately model blood vessels and the 
human vasculature, we chose the simple, linear 1-D wave equation to model blood flow 
hoping to emphasize the wave like nature of blood flow within a vessel.  Thus extending 
Eq. 4, I used  
2
2
2
2
2
x
Qc
t
Q
∂
∂=∂
∂     (16) 
where the wave speed, c, is defined by Eq. 5.   
 
Attempting to imitate some of the anatomical dimensions of the larger pulmonary 
arteries, I utilized vessel properties estimated from literature [23] to construct five 
frictionless tubes attached to a pump which stimulates flow at the origin, (Q(0,t)), and at 
the outlet to a long frictionless tube intended to provide an escape for the fluid while 
stimulating a small resistive force to create a reflected wave.  The properties assigned to 
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the vessel created a wave speed near ~2 m/s which was consistent with the slower wave 
speeds found within the larger arteries of the pulmonary vascular system.  The vessel 
properties used in the model can be found in Table 1. 
Table 1 Defined Dimensions and Properties Used in Test Models.  The dimensions are very small 
and have been determined given literature [23] and with infant pulmonary vasculature values in 
mind. 
 Length 
(cm) 
Internal 
Radius 
(cm) 
Wall 
Thickness 
(cm) 
Elastic 
modulus 
(dynes/cm^2) 
co – Wave 
Speed (m/s) 
Total 
Model 
Length 
(cm) 
Model 1 – Control Model (No Stent) 
Vessel 5 0.18 0.078 15 1.751 5 
Model 2 – Stent Design 1 
Vessel 4 0.18 0.078 15 1.751 
Transition 
Region (2) 
0.45 0.18 0.088 15 - 150 1.751 - 
5.537 
Rigid Region 0.1 0.18 0.088 150 5.537 
5 
 
Model 3 – Stent Design 2 
Vessel 4 0.18 0.078 15 1.751 
Transition 
Region (2) 
0.8 0.18 0.088 15 – 150 1.751 - 
5.537 
Rigid Region 0.2 0.18 0.088 150 5.537 
5 
Model 4 – Stent Design 3 
Vessel 4 0.18 0.078 150 1.751 
Transition 
Region 
0.8 0.18 0.088 15 – 150  1.751 - 
5.537 
Rigid Region 0.2 0.18 0.088 150 5.537 
5 
Model 5 – Stent Design 4 
Vessel 4 0.18 0.078 15 1.751 
Rigid Region 1 0.18 0.088 150 5.537 
5 
 
In order to test the simple design under various flow conditions and flow rates, I defined 
the action of the pump as a sinusoidal function, (g(t)).  We tested the flow at rates of 4 
Hz and 3 Hz to better compare its results with those seen in an earlier  set of data from 
the porcine models of our corresponding PAH investigation with two different sinusoidal 
functions, (g1(t)) and (g2(t)).   
 
In our simulation, the long frictionless tube at the end of the model was defined as 
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∂ tlwtl
t
Q     (17) 
where w(l,t) is constant, and the vessel began at a zero state condition defined by 
0)()0,( == xfxQ     (18) 
0)()0,( == xh
dt
xdQ     (19) 
From there we incremented time steps to calculate the amount of flow located at each 
node within the vessel model using the 1-D, time dependent solutions calculated by 
{ } { } { })][(][ 00120 uKFMu −= −&&   (20) 
{ } { } { }FuKuM =+ ][][ 2 &&    (21) 
{ } { } { } { } { }sssss uauauuau &&&&& 54131 )( −−−= ++  (22) 
{ } { } { } { } 1121 ++ ++= ssss uauauu &&&&&&   (23) 
where M, K, and F represent FEM matrices calculated using quadratic elements and the 
wave equation.  u , u& , and ü  represent the solution and its time derivatives at each point 
within the model, and the coefficients a1, a2, a3, a4, and a5 constitute stability and 
accuracy parameters defined by 
ta Δ⋅=α1      (24) 
ta Δ⋅−= )1(2 α     (25) 
)(
2
23 t
a Δ⋅= γ      (26) 
)(
2
4 t
a Δ⋅= γ     (27) 
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1
1
5 −= γa      (28) 
where Δt is the change in time and α and γ are two parameters assigned the values of 3/2 
and 8/5, respectively, for the Galerkin method [24]. 
 
Of the five vessel models, we used one as the control and placed three generic stent 
designs into the other four models.  All three simplified, 10 mm long designs were 
placed 2 cm from the origin of their vessel models altering the properties of their 
respected vessels at those locations.  At the most rigid locations of the stent the elasticity 
of the vessel increased by a factor of ten, and, at other locations in the stented regions, a 
linear transition function was utilized to describe the elasticity. The intent of our 
transition model was to simulate the effect of a compliant matching stent [19].   
 
Fig. 2 shows the three different stent designs in their respected orientations within their 
designated vessel models.  As shown, we utilized the basic concept of the compliance 
matching stent (CMS) with a transition region at both ends where the elasticity was 
defined as a function of the location, E1(x), with a rigid reinforced center.  We also 
utilized a uniform rigid stent to create sharp contrasts at both ends of the stent within the 
vessel model.  We then created a hybrid of the two models and oriented the compliant 
end proximally or distally to the origin. These two models denoted CMSP (proximal 
orientation) and CMSD (distal orientation) had values for elasticity defined by another 
function, E2(x).   
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Using the same linear, frictionless assumptions applied to the vessel model, I calculated 
the pressure at each location in the vessel model utilizing space and time derivatives and 
assuming that vessel deformations were small compared to the radius of the vessel given 
dx
dV
C
A
dt
dP −=      (29) 
dx
dP
dt
dV
ρ
1−=      (30)      [25] 
A
QV =       (31) 
where P is pressure, A is the area at mean pressure, C is compliance of the tube, and V is 
the velocity of blood.   
 
 
Fig. 2 Generic Stent Model Designs. The four stent designs are generic, conceptualized models 
designed to imitate the elastic properties of a compliance matching stent (CMS) and a uniformly 
rigid stent.  CMSP and CMSD are hybrid designs of the uniformly rigid and CMS stent with the 
compliant end oriented proximally to the origin (CMSP) and distally to the origin (CMSD).  The 
origin of the model would be located to the left of each design and the vessel outlet would be located 
to the right. Dimensions are in mm. 
 
Using pressure and flow measurements taken at five different locations in each vessel 
model (Fig. 3), the pressure, flow, and the impedance of the vessel models could be 
evaluated using the same methods used to evaluate the PAH animal models.  Again, the 
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measured waves were decomposed into the DC and the forward and backward AC 
components, and the impedance, energy, and power of each system were compared.  
 
Fig. 3 Approximate Measurement Positions of the 5 cm Test Models. Position A is located 1 cm 
from the origin.  Positions B and D are located 1 mm before and after the region of the vessel where 
the different stent models were located.  Position E is located 4 cm from the origin and Position C is 
located in the middle of the vessel model. 
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CHAPTER III 
RESULTS 
Hemodynamic PAH results 
Analysis of the time averaged parameters revealed that P  was significantly higher in the 
controls compared to the diseased animals. In the controls, P  was 34.1±2.0 mmHg 
compared to 19.8±2.4 mmHg in the diseased (Table 2).  More variation was seen 
between the diseased animals as they ranged from 18.8 mmHg to 23.1 mmHg compared 
to 32.4 mmHg to 36.9 mmHg in the control.  Time averaged Q  in the controls was 
slightly higher than the diseased animals, but the difference was not significant. The 
diseased animals had a Q  of 51.9±16.1 mL/s compared to 59.9±15 mL/s in the controls. 
More variation was present in both sets of data as Q  in CS1, CS2, and CS3 ranged 
between 40.02±2.3 mL/s and 74.26±3.2 mL/s in CS2 and CS3, respectively, and Q   
rates fell between 78.27±2.2 mL/s and 33.63±0.56 mL/s in DS1 and DS4, respectively. 
Though no significant difference was present between the average Q  of the Controls 
and the Diseased, individually Q  in DS1, DS2, DS3, and DS4 showed significant 
difference from the controls.  
 
The magnitude of the pulsatile pressure components (|P|) indicated that the diseased 
subjects had a significantly higher |P| than the controls in the first and second harmonics. 
The |P| in the diseased subjects was also significantly higher after the fourth harmonic.  
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Table 2 Summary of Hemodynamics of Porcine PAH Study. * indicates values which were 
significantly different from the averages (AVG) seen in the controls. 
SUBJ P  
(mmHg) 
Q  
(mL/s) 
ZC 
⎟⎠
⎞⎜⎝
⎛ ⋅
mL
smmHg  
PVR  
⎟⎠
⎞⎜⎝
⎛ ⋅
mL
smmHg  
CS1 33.0 ±0.2 65.3±2.4 0.0540±0.024 0.506±0.019 
CS2 32.4±0.2 40.0±2.3 0.0634±0.018 0.811±0.046 
CS3 36.9±0.2 74.3±3.2 0.0516±0.0091 0.498±0.022 
AVG 34.1±2.0 59.9±15 0.0563±0.018 0.605±0.15 
DS1 18.8±0.1* 78.3±2.2* 0.072±0.016 0.240±0.0061* 
DS2 16.6±0.2* 44.1±3.0* 0.0994±0.024* 0.378±0.023* 
DS3 20.4±0.1* 52.5±1.8* 0.112±0.008* 0.390±0.013* 
DS4 23.1±0.2* 33.6±0.56* 0.390±0.052* 0.688±0.015* 
AVG 19.8±2.4* 51.9±16.1 0.169±0.13* 0.423±0.17* 
 
As shown in Fig. 4, there was a large amount of deviation in the diseased subjects. 
However, closer observation indicated that the increased magnitude in the first harmonic 
is largely due to DS4 whose magnitude was more than double (>10 mmHg) that of DS1, 
DS2, and DS3 (<= 5 mmHg). A similar observation was made in the second harmonic, 
but there were no significant differences between the control and diseased subjects in the 
second harmonic.  
 
The flow magnitude (|Q|) in the frequency domain, shown in Fig. 5, was higher in the 
control subjects throughout the first ten harmonics, and the differences were significant 
in all but the third harmonic.  Similarly to |P|, a larger deviation was also present in the 
first harmonic in the diseased set, but the deviation couldn’t be contributed to only one 
animal perhaps reflecting the differences in Q  seen between the diseased animals. 
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Fig. 4  Pressure Magnitude in the Frequency Domain.  The diseased subjects (red) had higher P 
magnitudes in the first and higher harmonics than the control (blue). The diseased subjects deviated 
more from animal to animal than the control, and the deviation was more pronounced in the lower 
harmonics. 
 
PVR was significantly higher in the control subjects compared to the diseased subjects. 
The PVR in the control subjects was 0.605±0.15 mmHg*s/mL compared to 0.423±0.17 
mmHg*s/mL.  The PVR did vary from animal to animal however. The values of P  and 
Q  resulted in the PVR’s of 0.506±0.019 mmHg*s/mL, 0.811±0.046 mmHg*s/mL, and 
0.498±0.022 mmHg*s/mL for CS1, CS2, and CS3, respectively, while DS1, DS2, and 
DS3 had values of 0.240±0.0061 mmHg*s/mL, 0.378±0.023 mmHg*s/mL, and 
0.390±0.013 mmHg*s/mL which were all significantly different. DS4 was higher than 
the control average at 0.688±0.015 mmHg*s/mL and was significantly different. 
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Fig. 5 Flow Magnitude in the Frequency Domain.  The control subjects (blue) had higher Q 
magnitudes than the diseased subjects (red), but not significantly. The deviation appeared to be 
comparable in both subjects. However, it is slightly larger in the diseased subjects. 
 
The diseased group exhibited a higher impedance magnitude (|Z|) in the first ten 
harmonics in the frequency domain and the difference increased significantly after the 
third harmonic. As shown in Fig. 6, the higher |Z| values had higher standard deviation 
values associated with them. The standard deviation also increased with frequency in the 
controls as well. Closer observation of the |Z| showed that DS4 tended to have the 
highest |Z| of the diseased subjects. However, DS1, DS2, and DS3 still had higher |Z| 
values than the controls. The higher |Z| values contributed to the significantly higher ZC 
in the diseased subjects compared to the controls. Individually, DS2, DS3, and DS4 all 
had significantly higher ZC than the controls, but the increase was not significant in DS1. 
The differences in PVR and ZC are summarized in Table 2. 
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Fig. 6 Impedance Magnitude in the Frequency Domain. The diseased subjects (red) had higher Z 
magnitudes than the diseased subjects (red). The increased impedance his higher at higher 
frequencies, but the deviation increases at higher frequency as well. The increased |Z| reflects the 
increased ZC expected in hypertension. 
 
 
In all three controls shown in Fig. 7, the anterograde waves reached a maximum at peak 
or near peak systolic pressure (P), and retrograde waves hit a minimum at peak flow (Q) 
when P was only beginning to increase. The diseased animals were different from the 
controls as the maximum anterograde value and minimum retrograde values occurred 
nearly simultaneously at peak systole. Also, the retrograde waves reached a maximum 
later in diastole in DS1, DS2, DS3, and DS4 than in the controls. These maxima in the 
diseased then tended to be at or near the resting diastolic retrograde wave values in DS1, 
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DS2, and DS3. In the CS1, CS2, and CS3, the retrograde waves achieve a maximum 
value right after the anterograde peaked in late systole/ early diastole. 
 
The consistent P and Q profiles in CS1, CS2, and CS3, provided consistent forward 
(anterograde) and backward (retrograde) wave decompositions in the time domain. 
Meanwhile in the diseased animals, shown in Fig. 8, the anterograde and retrograde 
waves were consistent in each respective animal but not between animals. The 
consistency in the controls reflected the lower deviation and smaller ranges seen in the 
measurements of the controls. They also reflected a baseline condition of healthy 
animals rather than the various conditions of the diseased animals. The various 
differences in the conditions of the diseased animal were the most obvious in the 
differences in between DS1 and DS4. DS1’s measured and retrograde waves contrast 
those of DS4 which are both distinct. In fact, with the exception of DS4, the retrograde 
waves in the diseased animals tended to be much flatter than the controls.  
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Fig. 7 Separated Forward and Backward Waves in the Control Subjects. Typical measured P and 
Q (blue) beats of CS1, CS2, and CS3 showed little variation between beat. The forward propagating 
waves (green) appear to peak later at peak systolic P, while retrograde waves (red) reach a 
minimum early in systole peaking at peak Q. The retrograde waves attain a maximum value during 
late systole/ early diastole at nearly the same time as peak P and maximum forward propagating 
waves. In addition to the mean values (dashed pink) the retrograde and anterograde waves compose 
the measured wave. A shoulder could be seen in measured P prior to peak systole along with a 
standard exponential decay that ended with a slight increase in measured P midway through 
diastole. The increase coincided with the second hump seen in measure Q. Each had a period of 
approximately 0.5 seconds. 
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Fig. 8 Separated Forward and Backward Waves in the Diseased Subjects. Typical measured P 
and Q (blue) beats of DS1, DS2, DS3, and DS4 showed more variation between each animal than the 
control. The forward propagating waves (green) appear to arrive at peak systole along with the 
retrograde wave (red) minimum. The retrograde maximum occurs later in diastole than in the 
controls, and the maximum appeared to be at or near a consistent retrograde diastolic value. These 
two waves in addition with the mean value (dashed pink) compose the measured wave. The shoulder 
seen in measured P prior to peak systole in the control subject isn’t present. The measured P 
profiles in DS1 and DS3 where much broader and flatter than the controls. DS2 looks the most 
similar of the diseased subjects to the control subjects. It appears the increased BPM in DS4 could 
have influenced its measured P profile, and it could be related to the diminished Q. 
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Measured P in each of the controls had a shoulder prior to peak systole which was not 
present in the diseased animals. This shoulder reflected the arrival of peak Q in the 
control. The peak Q in the diseased animals arrived at peak P thus there was no shoulder. 
Measurements in the P and Q in the diseased and control animals also differed in the 
diastolic exponential decays. The control animals displayed similar exponential decays 
with a slight rise in diastole. In P, the decay ended midway through diastole and 
coincided with the second hump also seen in the Q measurements. In DS1 and DS3, the 
P waves didn’t show this attribute and were instead much broader and flatter than any of 
the controls. Meanwhile, DS2 had a sharper peak with a more pronounced decay than 
the other DS1 and DS3 animals and even showed a small hump similar to the controls. 
However, DS4 was different than the other diseased and control animals. It had a large 
systolic increase and a quick decay into another beat. This occurrence was most likely 
the result of a decreased period and increased heart rate to compensate for decreased Q.  
 
Of note in each animal was that Q led P. Q wave shapes were also similar between the 
diseased and control animals despite different Q  values. One irregularity was noticed in 
CS2, but may have been due to noise in these measurements. The noise tended to be 
more pronounced at the foot of the Q wave which, in this case, caused a global 
minimum. 
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The hearts of the control subjects appeared to deliver more PD to the pulmonary 
vasculature than their diseased counterparts (Table 3). The hearts of CS1, CS2, and CS3 
delivered 592.5±22.8, 371.6±21.3, and 764.1±33.0 mW which was significantly higher 
than all of the diseased subjects. Of the diseased subjects, DS2’s heart delivered the least 
amount of power with only 137.2±8.7 mW per beat on average, and DS1’s heart 
delivered the most amount of power at 235.6±5.8 mW per beat.  It was also notable that 
DS4’s increased heart rate allowed it to deliver 210.3±81.8 mW. DS3 delivered 
166.5±5.2 mW. 
Table 3 Energy and Power Summary of Hemodynamics in the Porcine PAH Study. * indicates 
values which were significantly different from the averages (AVG) seen in the controls. 
SUBJ Heart Rate (bpm) PD (mW) ED (mJ) 
CS1 125 592.5±22.8 140.7±5.2 
CS2 127 371.6±21.3 87.2±4.9 
CS3 127 764.1±33.0 179.9±6.9 
AVG 127±2.1 576.1±164 136.0±39 
DS1 111* 235.6±5.8* 126.9±3.2 
DS2 111* 137.2±8.7* 75.9±2.7* 
DS3 125* 166.5±5.2* 79.5±2.5* 
DS4 201* 210.3±81.8* 46.8±0.50* 
AVG 129±38.5* 181.9±48* 81.7±29* 
 
The increased, consistent heart rates in the controls seemed to make up for some of the 
differences in ED per beat between the diseased and control animals, but ED was still 
higher in the controls.  CS1, CS2, and CS3 delivered 140.7±5.2 mJ, 87.2±4.9 mJ, and 
179.9±6.9 mJ, respectively, at a consistent heart rate of 126.6±2.1 beats per minute 
(BPM).  DS1, DS2, DS3, and DS4 on the other hand delivered 126.9±3.2 mJ, 75.9±2.7 
mJ, 79.5±2.5 mJ, and 46.8±0.50 mJ, respectively, at a hear rate of 128.9±38.5 bpm. 
More specifically, DS1 delivers more energy per beat than CS2, but with less beats per 
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minute (111 bpm versus 127 bpm) it delivers less power. DS4 delvers a lot of power at 
the highest heart rate (201 bpm), but it can’t compensate for the little amount of ED . 
DS2 had one of the lowest heart rate (111 bpm) and the second lowest ED hence it had 
the lowest PD. 
 
Stented wave model results  
The changes associated with different stent designs  
The deployment of a stent reduced the amplitude differences between the upstream and 
downstream ends in the idealized vessel model, and also had a minor effect on the 
arrival times of the Q and P waves. The unstented control model (Control) had an 
increase in amplitude in the primary wave from point B, 1 mm proximal of the stent, to 
point D, 1 mm distal of the stent (see Fig. 3). The amplitude of this primary wave 
increased from point B to point D by 34.9% in P and 14.3% in Q (Fig. 9). The uniformly 
rigid stent provoked a substantial decrease in the difference in amplitudes between point 
B and point D, with a change of 6.8% in P and 2.5% in Q. The compliance matching 
stent (CMS) model gave similar reductions of 8.4% and 3.1% between point B and point 
D in P and Q, respectively.  The rigid-compliant hybrid model with the compliant end 
oriented proximally to the origin (CMSP) similarly showed a 14.3% and 5.4% amplitude 
reduction in P and Q, respectively. The rigid-compliant hybrid model with the compliant 
end oriented distally to the origin (CMSD) differed slightly from our other hybrid model 
with a 9.7% and 3.7% change from point B to point D in P and Q, respectively.  
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Fig. 9  Pressure and Flow Waveforms in the Simulated Vessels. Given a stimulated cosine input, 
the P and Q profiles in our stented models all showed a diminished amplitude in P and Q at point B 
(blue) and point D (red) compared to the unstented model. The stents also make the difference in 
amplitude between point B and point D smaller. 
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An inspection of the arrival times showed that the local maxima of P and Q in all of our 
stented models were within 0.016 s of the arrival time of the unstented control. The 
global maxima (the maxima associated with the larger, primary waves) seen in both P 
and Q occurred 0.002 s later in the unstented model compared to all of the stented 
models, and there was no difference in arrival time between the uniformly rigid stent, 
CMS, CMSP, or CMSD. The second, local maximum yielded slightly different results, 
but the peak values still occurred earlier in all of the stented models. Overall, the waves 
propagated faster in the stented models with peak P occurring 0.004±0.001 s earlier and 
peak Q occurring 0.010±0.0034 s earlier. These changes were expected but small given 
our model size and the calculated wave speeds shown in Table 1.   
 
The relationship in time between peak P and peak Q by a ∆t was zero in the primary 
wave but not the secondary wave. However, the second peak had a different ∆t in each 
model, and the ∆t differed at point B and point D. The unstented model had the smallest 
∆t with only 0.005 s between peak P and Q while the CMS model had the largest ∆t with 
0.018 s at point B. The CMS also had the largest difference in ∆t between point B and 
point D of any of the models, possibly indicating that it more substantially decoupled the 
upstream and downstream ends of the vessel. 
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Fig. 10 Calculated |Z| in the Simulated Vessels. The presence of a stent within a vessel decreased 
the |Z|. The stents also altered the relationship between the proximal |Z| and distal |Z|. The amount 
each stent affected the |Z| can be observed in the differences in ZC. 
 
 In our frequency analysis, it became evident that the stents not only decreased the |Z| of 
the vessel, each design also altered the relationship between the apparent |Z| at the 
upstream and downstream ends which could indicate a wave filtering capability. In our 
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unstented model, shown in Fig 10, the |Z| increases with frequency with |Z| being higher 
at point D below 24 Hz and point B above 24 Hz. This changed with the application of a 
stent as all four stent models maintained a much lower |Z| than the unstented control 
after the first harmonic. The stented models also maintained a lower |Z| at point B than 
point D. The uniformly rigid stent |Z| peaked at 8 Hz before decreasing throughout the 
rest of the first ten harmonics while the CMS model’s |Z| increased up to 12 Hz before 
decreasing similarly. The hybrid models, CMSP and CMSD, also give similar results 
with CMSP mirroring the uniformly rigid stent model and CMSD mirroring the CMS.  
 
Summarizing the changes in |Z| of all the models, our calculations indicated that the 
stents would change the relationship between the ZC of the upstream and downstream 
ends (Summarized in Table 4). In the unstented model, the ZC of the vessel is 1.7 % 
lower at point B compared to point D. The application of a uniformly rigid stent 
increases this difference to 9.8% while the CMS increases it even more to 12%. These 
changes indicated in these two models are further amplified in hybrids. In addition the 
hybrids indicated that the orientation of the compliant end can have an impact. The 
CMSD model indicates that ZC is 14% lower at point B compared to point D and this 
difference increased to 19% in CMSP. 
Table 4 Summary of the Difference in ZC at Positions B and D in Computer Models. Measurements 
are in mmHg*s/mL. The presence of a stent and the presence or orientation of a compliant region 
within a stent affect the relationship between P and Q and changes the ZC.  
Characteristic 
Impedance, 
ZC 
(mmHg*s/mL) 
Unstented 
Control 
CMS CMSP CMSD Uniformly 
Rigid 
Point B 0.56678 0.21904 0.15043 0.25927 0.14733 
Point D 0.57666 0.24844 0.18520 0.30024 0.16327 
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The application of a pure cosine stimulus 
Applying a pure cosine wave to our stent models reflected the results of our original 
calculated amplitudes, but it didn’t reflect the changes in impedance. The changes in 
amplitude can be best summarized by Fig. 11, where one can discern the overall 
decrease in amplitude of the primary and secondary waves with the application of the 
CMS. This same result was observed with each of the stent designs. However, the 
change to a pure cosine stimulus at the origin did cause a change in impedance in each 
model. Summarized by Fig. 12 and Table 5, the apparent |Z| decreased in the unstented 
control model but increased in each of the stented models. The |Z| of each subject also 
stayed relatively constant throughout the first ten harmonics. In the end, these |Z|’s 
resulted in an observed 25% decrease in ZC of the unstented control model and a 140%, 
59%, 119%, and 32% increase in the ZC of the uniformly rigid stent, CMS, CMSP, and 
CMSD models taken at point D in the first and second set of simulations, respectively. 
With this noticeable change, we also observed a decrease in the difference in ZC of the 
proximal and distal measurement sites. The unstented model had a ZC that was 10% 
lower at point B than point D. This value decreased to 3.7%, 4.3%, 6.4%, and 4.9% in 
the uniformly rigid stent, CMS, CMSP, and CMSD models, respectively.   
Table 5 Summary of the Differences in ZC at Position B and D in Cosine Simulations. 
Measurements are in mmHg*s/mL. The little change observed in |Z| indicated almost no change in 
ZC. 
Characteristic 
Impedance, 
ZC 
(mmHg*s/mL) 
Unstented 
Control 
CMS CMSP CMSD Uniformly 
Rigid 
Point B 0.38339 0.37723 0.37944 0.37779 0.37682 
Point D 0.42715 0.39435 0.40556 0.39714 0.39124 
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Fig. 11  Pressure and Flow Waveforms in Cosine Simulations. Given a stimulated cosine input, the 
P and Q profiles in our stented models all showed a diminished amplitude in P and Q at point B and 
point D compared to the unstented model. The stents also make the difference in amplitude between 
point B and point D smaller. 
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Fig. 12 Calculated |Z| in the Cosine Simulations. The presence of a stent in a vessel given a 
simplified cosine wave stimulus indicate that a stent had no effect on |Z|.  
 
The effects of stent relocation 
The result of moving a stent upstream and applying a similar Q wave yielded changes in 
amplitude and ZC similar to those observed in our first simulations. The changes in 
amplitude can be best summarized by the changes observed between our unstented 
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control model and the CMS model shown in Fig. 13.  Each of the models indicated that 
the stent decreased the amplitude of P and Q in a way similar to what is seen between 
the unstented control and the CMS model. We also observed similar changes in |Z| as the 
models demonstrated a decrease in |Z| after the first harmonic with a stent design 
present. Consequently, these |Z|, shown in Fig. 14, led to an overall decrease in ZC 
compared to the unstented control. However, given these similarities, the simulations 
indicated that there were changes between the ZC measured at point B and point D 
between this simulation and the first simulation. This indicated that the stent’s location 
in reference to the origin had an influence on the |Z|. Summarized in Table 6, the ZC 
increased compared to the first simulations at point B and point D in the uniformly rigid 
stent model and the CMSD model. The ZC also increased at point B and point D in the 
CMS and CMSP models, respectively, but the ZC decreased at point D and point B in 
these same models, respectively. 
Table 6   Summary of the Difference in ZC at Positions B and D in Relocated Stent Simulations. 
Measurements are in mmHg*s/mL. The stents decreased the ZC compared to unstented control, and 
the ZC’s changed in comparison to the first simulations. Values which increased are highlighted in 
red and values that decreased are highlighted in blue. 
Characteristic 
Impedance, 
ZC 
(mmHg*s/mL) 
Unstented 
Control 
CMS CMSP CMSD Uniformly 
Rigid 
Point B 0.56678 0.18163 0.15276 0.19905 0.11194 
Point D 0.57666 0.25534 0.16960 0.28777 0.14520 
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Fig. 13 Pressure and Flow Waveforms in Relocated Stent Simulations. The P and Q profiles in the 
stented models indicate that the amplitude of P and Q at point B and point D were diminished 
compared to the unstented control model. The difference in amplitudes between point B and point D 
were also decreased. 
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Fig. 14 Calculated |Z| in Relocated Stent Simulations. The results of the relocating the stent 5mm 
upstream of its original still showed a decrease in |Z| compared to our unstented control model. 
Subtle differences in |Z| were indicated by the ZC calculations which could signify that a stent’s 
location in reference to the origin has a very small impact on ZC. 
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CHAPTER IV 
SUMMARY AND CONCLUSIONS 
Porcine model of PAH 
As expected, the progression of pulmonary arterial hypertension alters the 
hemodynamics associated with the pulmonary vasculature, but it has yet to be 
determined whether these changes in turn continue to drive its progression. The 
development of the monocroatiline porcine PAH model analyzed in this study could be a 
valuable step toward better understanding the relationship between the progression of 
PAH and its associated hemodynamics. The increases in impedance found in this study 
parallel the hemodynamic changes seen in systemic hypertension [12,13] and in previous 
studies of PAH [26,27,28,29].  Since the ZC is related to the compliance, cross sectional 
area, and wall thickness, the increase in ZC would indicate possible changes in all three 
variables. Given the relationship between ZC, compliance, (C) and area, (A), shown by  
⎟⎠
⎞⎜⎝
⎛
Δ
Δ=
P
rrC π2                                    (32) 
AA
PZC )(Δ
Δ= ρ                                    (33) 
 a decrease in the compliance of the pulmonary vasculature of vessel and in the total 
cross sectional area of the pulmonary vascular bed would both increase the ZC. 
Furthermore, any increase in the thickness of the vessel walls would decrease 
compliance contributing to the observed elevated ZC[26,28,29].  All of these changes in 
our model reflect the vascular remodeling occurring as the disease progresses [30]. The 
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muscularization of the smaller arterioles would decrease the total cross sectional area of 
the vascular bed causing an increase in ZC and PVR. This migration/proliferation of 
smooth muscle cells into these tissues would also increase the thickness of the vessel 
walls, thereby decreasing the compliance and increasing ZC. In addition, the strain 
stiffening characteristics of the arteries of the pulmonary vasculature would cause a 
decrease in compliance under the increased strain of a higher blood pressure. This result 
would be analogous to the increasing difficulty of inflating an already very inflated 
basketball compared to a less inflated one. 
 
As with any study, there are limitations imposed upon the experiment by the model, and 
in this study it appears that the acquisition of the data could have had an impact on the 
data itself. Previous studies of PAH have utilized monocroatiline and rodent models 
[26,28,29], and other animal models have also been utilized to perform studies on other 
kinds of pulmonary hemodynamics [27], but, to the authors knowledge, this is the first 
attempt to use a full size, monocroatiline swine model under anesthesia. With this 
model, many parameters affect the acquisition of data and some of these parameters may 
be difficult to control while acquiring data. These parameters include the depth of 
anesthesia, the amount of saline administered to the animal, and the method used to 
mechanically open the chest to place the Q probe around the pulmonary artery. 
 
Considering the difficulty in acquiring data, we recognized that the higher PVR and P  
seen in the control subjects (0.605±0.15 mmHg*s/mL and 34.1±2.0 mmHg, 
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respectively) could have been the result of the anesthesia or another contributing factor. 
The uncharacteristically high P  and results of previous studies of the PAH indicate that 
the PVR should be elevated in the diseased subjects rather than the controls assuming 
the same body mass and blood Q through the pulmonary vasculature. This didn’t appear 
to be the case in our analysis. However, we discovered that the hearts of the control 
animals were still maintaining a higher level of PD  and ED per beat. This could be an 
indication of the health of the heart and lungs of these animals since they are still 
capable of sustaining an increased afterload and a short period of increased P .  This 
observation would also be consistent with the ability of a healthy right heart and lungs to 
withstand considerable preload, but at these elevated P  these healthy hearts might be 
prone to dilation of the right ventricle [7,31]. 
 
Though unexpected [29], the apparent decreased PVR of the diseased animals in relation 
to the control could have occurred under a few specific situations. Originally, we 
considered side effects of the surgical procedure similar to those described above, but we 
also theorized that a more advanced diseased state and remodeled vasculature could have 
placed such an increased amount of stress on the heart that the subject was unable to 
maintain normal function. This idea was illustrated by the decreased PD and ED per beat 
seen in the diseased subjects. It was expected that a healthy animal would at least be 
capable of maintaining the same amount of PD, despite a decreased ED per beat, with an 
increase in heart rate similar to the one observed in DS4. However, this was not the case 
in the DS1, DS2, and DS3. Therefore, their hearts may not be capable of maintaining PD.  
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In a second situation, we noted the observed changes in P  and Q  between the diseased 
and control subjects, and theorized that the animals were simply not capable of 
maintaining as much Q.  In the diseased condition, we expect an increase in P  assuming 
that the animal maintains Q . However, if the animal isn’t stressed, it seemed feasible 
that an animal would have a lower P  corresponding to the diminished Q . If this were 
the case, the diseased animals may have been physiologically sick compared to the 
controls and simply incapable of maintaining a high P  or Q  in the pulmonary 
vasculature. 
 
In our final theory, we postulated that the animals were at a stage in the development of 
the disease where the diseased changes in the pulmonary vasculature have not yet 
become significant enough to increase P  or PVR. The diseased subjects all had a higher 
|Z| and ZC compared to the controls which would indicate that the pulmonary vasculature 
had begun remodeling, but a significant amount of remodeling may need to occur before 
an increase in P  and PVR can be observed. This observation may be synonymous with 
undiagnosed early stages of the disease in humans where the symptoms haven’t 
manifested enough to hinder normal everyday activities.  Should this be the case early, 
noninvasive detection of changes in |Z| and ZC may help to detect the development of 
PAH in individuals prone its development.  
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With the difficulty associated with acquiring data and the uncertainty of our results, it 
might be beneficial to utilize another method to measure the pulmonary blood Q and 
blood P for future studies of the hemodynamics associated with the advancement of 
PAH in a porcine model.  A noninvasive method of measuring blood Q in addition to 
acquiring P with a pressure catheter would at least decrease the effects of saline 
administration and mechanically opening the chest. The measurement catheter would 
just need to be located within the vascular tree and the Q would need to be extracted 
from the same location via an imaging modality such as MRI or ultrasound. Another 
method to better study the hemodynamic effects and eliminate the effects of anesthesia 
might be to isolate and remove the system of interest completely for characterization. 
Such an approach would be very similar to those done in PAH studies by Chesler and 
colleagues [26,28,29], but this approach may be more difficult given a swine’s size 
compared to those of mice. 
 
 Ability of a stent to alter wave propagation 
Our simplified models of a stented vessel indicate that stents do alter wave propagation 
in vessels. Given our PAH analysis and the calculations of forward and backward 
running waves, we focused much of our analysis on the |Z| and ZC of the different 
models, and we came to realize that a decrease in the |Z| and ZC would be the desired 
result of applying a stent. Our stent models demonstrated that the stents are capable of 
achieving this objective. They also indicated that the each stent design had a slightly 
different effect than the other stent designs. However, despite the changes in the |Z| and 
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ZC, a large difference between the proximal and distal ends of the vessel would need to 
be observed to indicate the presence of a filtering characteristic in a stent. This large 
difference would imply that a physiological signal is being prevented from returning past 
the stent from the periphery.  All of the stents models showed that the stents increased 
the difference between the proximal and distal ZC compared to our unstented control. 
Specifically, the uniformly rigid stent created the least amount of difference between our 
measurement locations, and the CMSP model appeared to create the greatest amount of 
difference.  This observation with our first set of simulations and the cosine simulations 
could indicate that the compliant end allows for the easy transfer of energy across the 
stent while the sharp contrast at the rigid end serves to prevent its return. Yet, these 
results can’t be conclusive. The difference in proximal and distal ZC in our third, 
relocated stent simulations contradicted the other two. It originally appeared that this 
phenomenon was caused by moving the location of the stent relative to the origin. The 
more likely cause though was moving of the stent relative to the measurement point B 
and point D. In this simulation, point B would have ended up inside of the stent which 
would have increased the dependence of ZC on the mechanical properties [25] of the 
stent rather than any changes reflections, Q, or P. 
 
Ability of a stent to mediate disease progression 
Even with these results, the application of a stent to mediate disease progression or to 
alter the hemodynamics associated with a progressive disease such a PAH or 
bronchopulmonary dysplasia would be an attempt to apply a local solution to a global 
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problem. In our results, we had hoped to see a major changes between the proximal and 
distal measurements, but the changes in amplitude and small changes in wave profile 
were likely not sufficient to provoke the intended global response or to alleviate disease 
progression given the size of the model. Furthermore, the original intent of the 
deployment of a stent has a local focus. As such, its designs were and still are driven by 
the local environment associated with a stenosis, balloon angioplasty, and the 
complications of previously failed stenting.  The issues in their designs coupled with 
current complications seen in angioplasty and associated with stent restenosis currently 
make an application outside its original intent to provide a serve as a scaffold for 
vascular healing risky and unnecessary.  
 
Moreover, from an engineering standpoint, a stent is small compared to the wavelength 
of P and Q.  Studies have shown that the effects of elastic nonuniformities are small 
given long wavelengths [32]. Therefore, the size of a stent should make its application as 
a filter small, and its effects on the impedance of a more complex system would be 
relatively negligible compared to the effects of bifurcations, pathlengths, or vascular 
constriction.  
 
Limitations and future directions 
Many limitations, assumptions, and restrictions impeded our analysis and the 
development of more conclusive theories. One of the larger of these assumptions was the 
size of the vessel and the size of the stent. The ratio between the size of the stent and the 
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size of the modeled vessel was quite a bit larger than it would be in a physiological 
setting, and, had the model been non-dimensionalized or enlarged, this simulation may 
have provided a better simulation for the application of a graft. Given this observation, 
we considered altering the length of the vessel and the models dimensions because the 
length might more adequately compare to the wavelength of a vessel. Yet such results 
were beyond the scope of the project.   
 
Our model’s design however was restricted most by the derivation of the wave equation 
and its assumptions: a straight, compliant tube, an inviscid fluid, small deformations, 
linear elasticity, and a wave speed much larger than blood velocity (c>>u). The most 
significant of these assumptions was the geometric straight tube assumption. 
Physiologically, a vessel would only be straight over a very short distance. Thus we 
restricted our vessel to a length of 5 mm, but, in hindsight, we would have preferred to 
add vessel tapering and bifurcations to more adequately simulate a stent in a bifurcating 
vascular system. These additions proved to be difficult though because of the linear, 
straight tube assumptions. 
 
Many changes could have been made to our original model design which could have led 
to more conclusive results. Most importantly, a more adequate non-linear model with 
bifurcations and vessel tapering would have had a profound influence on our results. 
Vessel bifurcations and tapering should have improved the frequency content of our 
calculated |P|, |Q|, and |Z| which, in turn, would have allowed us to better analyze a 
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stent’s ability to filter higher frequency content. To create such a complex, adequate 
system with bifurcations, vessel tapering, and a stented region, it may be required to use 
nonlinear equations and computational methods. Studies have already shown that 
nonlinear models are very capable of modeling the human vasculature [33,34] and blood 
flow [21], and some of the results of these simulations have even be validated by in vitro 
experiments [34,35]. Specifically, recent work by Matthys et al [34] have shown the 
accuracy of non-linear 1-D computational vascular networks.  An adaptation to this 
model by adding a stiffer less elastic region (a stent) could easily address our original 
questions in a systemic vasculature setting. For the sake of completeness, a model 
similar to theirs could also be adapted to simulate the pulmonary vasculature.  One could 
even validate such a model with in vitro testing which is something that has, to the 
author’s knowledge, yet to be done. Also, multiple mathematical models of the 
pulmonary vasculature currently exist [36] which could help expedite such an 
investigation.  
 
A final review of our simulation also noted our emphasis on the increased stiffness of a 
vessel with a stent, but it might be beneficial to investigate this phenomenon with a 
region of increased compliance. We chose to focus our study on the application of a 
stent because of its abundance of use in cardiovascular treatment. Considering the 
application of a device which restores or enhances the compliance of a vessel may 
produce contradictory or improved results. In theory, a more compliant region could 
create reservoir or an area in which to story energy within the vasculature. In turn, this 
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area could provide a cushion for disturbances and reflections propagating back from the 
periphery. 
 
Conclusions 
This porcine model of PAH could be valuable to improving our understanding of the 
progression of PAH and to evaluate therapeutic options, but more research will need to 
be devoted to establishing the connection between hemodynamics and the progression of 
PAH in this model.  However, we did identify changes in |Z| and ZC in the disease 
animals, and, since our stent models altered |Z| and ZC, it appeared that stents have an 
impact on wave propagation in a small vessel. Still, the small changes in P and Q 
produced by the stent, the small size of the stent in comparison to the wavelength, and 
stent complications indicated that a stent would probably not invoke the global response 
necessary to affect the progression of PAH or BPD. 
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